相关实验视频

Updated: Jul 1, 2025

Reconstruct Human Retinoblastoma In Vitro

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

视网膜母细胞瘤的管理:我们还在吗?

Vishal Raval¹, Arun Singh²

¹The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

|March 2, 2024

概括

动脉内化疗 (IAC) 改善了视网膜母细胞瘤 (RB) 治疗,但面临着可访问性和并发症挑战. 未来的研究重点是克服这些局限性,以改善RB管理.

科学领域:

眼科医生眼科眼科
儿科瘤学儿科瘤学
药理学药理学是指药理学的学科.

背景情况:

动脉内化疗 (IAC) 已经彻底改变了视网膜母细胞瘤 (RB) 管理,特别是在发达国家.
与传统的全身化疗相比,IAC提供了更好的全球救援率.

研究的目的:

审查当前IAC对视网膜母细胞瘤的策略的局限性.
探索新的治疗点和药物输送途径,以加强RB治疗.

主要方法:

在视网膜母细胞瘤管理中IAC的文献综述.
对当前治疗局限性和未来治疗前景的分析.

主要成果:

IAC提出了一些挑战,包括可访问性,成本,专业知识要求,局部眼部并发症和潜在的全身转移风险.
尽管有局限性,IAC代表了RB护理的重大进步.

结论:

解决IAC的局限性对于更广泛的应用至关重要,特别是在资源较少的环境中.
开发新的治疗点和输送方法对推进视网膜母细胞瘤治疗具有前途.

更多相关视频

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Published on: August 4, 2011

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

相关概念视频

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...